|
Marché Fermé -
Nasdaq
22:00:00 14/10/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 78,63 USD | -2,26% |
|
-2,75% | +140,02% |
| 12/10 | Spyre Therapeutics, Inc. : UBS optimiste sur le dossier | ZM |
| 06/10 | Les actions de Spyre reculent après la fixation du prix d’une offre d’actions de 350 millions de dollars | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2,26% | -2,75% | -13,40% | -20,54% | +140,02% | +274,43% | +505,78% | -62,65% | -53,40% | 7,35 Md | |
| -2,01% | -7,86% | -2,95% | +20,92% | +70,10% | +60,74% | +70,97% | +7,17% | - | 68,92 Md | |
| +0,51% | +6,24% | -12,72% | -0,13% | +4,58% | +6,84% | +59,49% | +193,62% | +4 930,87% | 51,9 Md | |
| +2,34% | +6,53% | +11,73% | +3,23% | +11,60% | +11,81% | +40,86% | -16,85% | +231,60% | 48,73 Md | |
| +0,51% | +1,51% | -1,38% | +26,07% | +16,24% | +27,96% | +31,43% | +6,15% | +247,77% | 43,13 Md | |
| +2,70% | -3,66% | -5,65% | +4,62% | +142,96% | +307,41% | +547,01% | +572,41% | - | 41,48 Md | |
| +0,69% | -3,44% | -0,66% | +14,65% | +15,69% | +9,52% | +96,59% | -1,12% | +1 015,10% | 39,96 Md | |
| +0,06% | -2,02% | +0,56% | +4,05% | +4,30% | +11,25% | +43,27% | -1,49% | +149,63% | 30,6 Md | |
| -2,21% | -10,09% | -1,18% | +23,01% | +54,71% | +35,34% | -0,73% | -55,54% | - | 26,01 Md | |
| -0,39% | -6,92% | -10,32% | -1,92% | -6,87% | -13,60% | -14,40% | -64,58% | - | 22,27 Md | |
| -0,85% | +4,24% | +14,23% | +29,54% | +21,16% | +18,30% | +9,16% | -13,88% | +119,87% | 22,06 Md | |
| +1,03% | -3,88% | -21,96% | -11,19% | -43,81% | -39,40% | +294,95% | +263,53% | +611,72% | 21,36 Md | |
| +1,11% | +2,05% | +3,56% | +15,01% | +9,79% | +19,29% | +157,90% | +230,44% | +2 011,75% | 17,21 Md | |
| +1,00% | +3,88% | +7,02% | +13,48% | +26,03% | +27,17% | +56,03% | -27,55% | +87,86% | 15,03 Md | |
| +2,15% | -1,24% | 0,00% | -0,83% | +180,86% | +156,32% | +365,04% | +1 667,06% | +777,18% | 15,32 Md | |
| +2,49% | +4,36% | +8,50% | +9,36% | +39,15% | +54,37% | +185,53% | +179,26% | +438,78% | 15,11 Md | |
| +1,70% | -0,62% | -14,31% | -14,52% | - | - | - | - | - | 14,91 Md | |
| +1,00% | +0,57% | +10,58% | +30,62% | +51,39% | +77,51% | +58,10% | -25,59% | +274,92% | 14,42 Md | |
| +0,27% | -1,66% | -5,19% | -18,29% | +11,78% | -6,44% | +439,90% | - | - | 13,31 Md | |
| +2,82% | +2,98% | +0,02% | +0,60% | -7,27% | -9,11% | -31,66% | -38,57% | +119,27% | 13,04 Md | |
| Moyenne | +0,63% | -2,37% | -1,68% | +6,39% | +39,07% | +54,19% | +153,43% | +156,21% | +783,07% | 27,11 Md | |
| Moyenne pondérée par Capi. | +0,50% | -3,10% | -1,74% | +9,25% | +37,13% | +50,95% | +127,68% | +129,49% | +1 121,46% |
- Bourse
- Actions
- Action SYRE
- Secteur Spyre Therapeutics, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
